Licensed Practical Nurse in Greene, NY Accepting Medicare
5 Licensed Practical Nurse nurses found. Showing 1 - 5
 Melissa Marie Collins, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 50 Birdsall St, Greene, NY 13778 Phone: 607-656-7176 |
Alyssa Passela, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 46 S Chenango St, Greene, NY 13778 Phone: 607-201-5321 |
Lisa Dutcher, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 40 S Canal St, Greene, NY 13778 Phone: 607-656-4161 Fax: 607-656-8872 |
Sandra Scott, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 61 S Chenango St, Greene, NY 13778 Phone: 607-875-4105 |
Jennifer Pecka, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 698 County Road 3a, Greene, NY 13778 Phone: 607-206-3769 |
News Archive
THL completes acquisition of Intermedix Corporation
Intermedix Corporation, a leading provider of revenue cycle management and software solutions to the emergency healthcare industry, today announced the completion of its previously announced acquisition by Thomas H. Lee Partners, L.P. from Parthenon Capital Partners and its minority shareholders including Glenview Capital Management.
New model predicts which COVID-19 patients are at higher risk for hospitalization
Cleveland Clinic researchers have developed and validated a risk prediction model (called a nomogram) that can help physicians predict which patients who have recently tested positive for SARS-CoV-2, the virus that causes COVID-19, are at greatest risk for hospitalization.
FDA food protection plan shows improvements
The U.S. Food and Drug Administration's Food Protection Plan Progress Report, released today in conjunction with the Interagency Working Group on Import Safety Action Plan Update, shows significant areas of activity to further improve the safety of America's food supply since unveiling its Food Protection Plan in November 2007.
Triphase's marizomib receives FDA orphan drug designation for treatment of multiple myeloma
Triphase Accelerator Corporation today announced that marizomib, its novel, potent proteasome inhibitor, has been granted orphan drug designation by the U.S. Food and Drug Administration's Office of Orphan Products Development for the treatment of multiple myeloma. The orphan drug designation will provide Triphase with 7-year marketing exclusivity for marizomib and other benefits upon FDA approval.
› Verified 3 days ago